Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
- T. Yoshida, Y. Ozawa, J. Matsui
- Medicine, BiologyBritish Journal of Cancer
- 25 February 2014
Eribulin exerted significant effects on EMT/MET-related pathway components in human breast cancer cells in vitro and in vivo, consistent with a phenotypic switch from mesenchymal to epithelial states, and corresponding to observed decreases in migration and invasiveness in vitro as well as experimental metastasis in vivo.
Mouse Toll-like Receptor 4·MD-2 Complex Mediates Lipopolysaccharide-mimetic Signal Transduction by Taxol*
- K. Kawasaki, S. Akashi, R. Shimazu, T. Yoshida, K. Miyake, M. Nishijima
- BiologyJournal of Biological Chemistry
- 28 January 2000
It is demonstrated that coexpression of mouse TLR4 and mouse MD-2 is required for Taxol responsiveness and that theTLR4·MD-2 complex is the shared molecule in Taxol and LPS signal transduction in mice.
Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors.
- D. Germolec, J. Spalding, M. Luster
- Biology, MedicineAmerican Journal of Pathology
- 1 December 1998
Difference in transcriptional regulatory function between c-Fos and Fra-2.
- T. Suzuki, H. Okuno, T. Yoshida, T. Endo, H. Nishina, H. Iba
- BiologyNucleic Acids Research
- 25 October 1991
Analysis of chimeric proteins between c-Fos and Fra-2 indicated that this difference is mainly attributable to their C terminal-half regions, which greatly expand the potential range of regulatory functions of the Fos family proteins.
Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors
- T. Yoshida, T. Hisamoto, M. Sata
- Biology, MedicineOncogene
- 5 October 2006
Data indicate that the reduction of Spred expression in HCC is one of the causes of the acquisition of malignant features and could be not only a novel prognostic factor but also a new therapeutic target for human HCC.
Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis.
- T. Shouda, T. Yoshida, A. Yoshimura
- BiologyJournal of Clinical Investigation
- 15 December 2001
It is shown that the mRNA for the endogenous cytokine signaling repressor CIS3/SOCS3 is abundantly expressed in RA patients, and induction of CIS3 could represent a new approach for effective treatment of RA.
Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-β1 production
- H. Ogata, T. Chinen, A. Yoshimura
- Biology, MedicineOncogene
- 20 April 2006
A novel role is provided in HCC development: in addition to the previously characterized oncogenic potentials, STAT3 enhances hepatic fibrosis through the upregulation of TGF-β1 expression, and SOCS3 prevents this process.
Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice.
- T. Yoshida, K. Ikuta, K. Takatsu
- Biology, MedicineImmunity
- 1 May 1996
Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors.
- D. Germolec, J. Spalding, M. Luster
- Biology, MedicineMutation research
- 1 June 1997
Disruption of the Golgi apparatus by brefeldin A inhibits the cytotoxicity of ricin, modeccin, and Pseudomonas toxin.
- T. Yoshida, C. Chen, M. Zhang, H. C. Wu
- Biology, ChemistryExperimental Cell Research
- 1 February 1991
...
...